Points to consider regarding the SABR-COMET trial
Authors:
- 1 February 2020
- journal article
- letter
- Published by Elsevier in The Lancet
- Vol. 395 (10222) , e19-E19
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Pulmonary Metastasectomy versus Continued Active Monitoring in Colorectal Cancer (PulMiCC): a multicentre randomised clinical trialTrials, 2019
- SABR-COMET: harbinger of a new cancer treatment paradigmThe Lancet, 2019
- Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trialThe Lancet, 2019
- Definitive Stereotactic Body Radiotherapy (SBRT) for Extracranial OligometastasesAmerican Journal of Clinical Oncology, 2017
- Local Treatment of Unresectable Colorectal Liver Metastases: Results of a Randomized Phase II TrialJNCI: Journal of the National Cancer Institute, 2017
- Risk Factors for Survival after Lung Metastasectomy in Colorectal Cancer Patients: A Systematic Review and Meta-AnalysisAnnals of Surgical Oncology, 2012